Related Experiment Video
Updated: Jul 16, 2026
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Cachexia in patients with advanced cancer.
1Fox Chase Cancer Center, Philadelphia, PA, USA. d_dell@fccc.edu
Clinical Journal of Oncology Nursing
|June 29, 2002
Summary
Early diagnosis and intervention for cancer cachexia can improve quality of life and prolong survival. Management involves addressing nutritional issues, symptoms, and utilizing an interdisciplinary approach for better patient outcomes.
Area of Science:
- Oncology
- Nutrition Science
- Palliative Care
Background:
- Cancer cachexia is a common condition in advanced cancer patients, leading to nutritional deterioration and wasting.
- It significantly decreases quality of life and patient survival rates.
- Conventional nutritional support is often ineffective due to metabolic alterations.
Observation:
- Early diagnosis and intervention are crucial for managing cancer cachexia.
- Management strategies include anti-inflammatory agents, fish oil, orexigenic agents, steroids, and progestational agents.
- Addressing symptoms like nausea, pain, and anemia is vital for improving food intake and reducing debility.
Findings:
- An interdisciplinary approach involving healthcare professionals, patients, and families is necessary for effective management.
- Counseling is highlighted as a cost-effective intervention that can be combined with other treatments.
- Nurses play a key role in aggressively correcting factors that decrease food intake and worsen debility.
Implications:
- Judicious and early use of interventions can decrease the significant morbidity and mortality associated with cancer cachexia.
- Improving nutritional status can enhance patient quality of life and prolong survival.
- A comprehensive, team-based strategy is essential for successful palliation of cancer cachexia.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...